Do analysts rate CGC or ACB?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Canopy Growth 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50

Does the media prefer CGC or ACB?

In the previous week, Canopy Growth had 12 more articles in the media than Aurora Cannabis. MarketBeat recorded 14 mentions for Canopy Growth and 2 mentions for Aurora Cannabis. Canopy Growth's average media sentiment score of 0.90 beat Aurora Cannabis' score of -0.72 indicating that Canopy Growth is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Canopy Growth 9 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aurora Cannabis 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Negative

Do analysts rate ACB or CRON?

Cronos Group has a consensus target price of $2.30, suggesting a potential downside of 28.57%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts plainly believe Cronos Group is more favorable than Aurora Cannabis. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50 Cronos Group 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60

Does the media refer more to ACB or CRON?

In the previous week, Cronos Group had 1 more articles in the media than Aurora Cannabis. MarketBeat recorded 3 mentions for Cronos Group and 2 mentions for Aurora Cannabis. Cronos Group's average media sentiment score of 0.64 beat Aurora Cannabis' score of -0.72 indicating that Cronos Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Negative Cronos Group 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer ACB or OGI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50 Organigram Global 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67

Does the media favor ACB or OGI?

In the previous week, Organigram Global had 1 more articles in the media than Aurora Cannabis. MarketBeat recorded 3 mentions for Organigram Global and 2 mentions for Aurora Cannabis. Organigram Global's average media sentiment score of 1.16 beat Aurora Cannabis' score of -0.72 indicating that Organigram Global is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Negative Organigram Global 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer ACB or SNDL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50 SNDL 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has higher valuation & earnings, ACB or SNDL?

SNDL has higher revenue and earnings than Aurora Cannabis. SNDL is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aurora Cannabis $247.82M 1.04 -$88.13M -$1.41 N/A SNDL $677.32M 0.47 -$11.29M -$0.06 N/A

Is ACB or SNDL more profitable?

SNDL has a net margin of -2.36% compared to Aurora Cannabis' net margin of -32.26%. Aurora Cannabis' return on equity of 4.37% beat SNDL's return on equity. Company Net Margins Return on Equity Return on Assets Aurora Cannabis -32.26% 4.37% 3.45% SNDL -2.36% -2.01% -1.67%

Does the media favor ACB or SNDL?

In the previous week, Aurora Cannabis had 1 more articles in the media than SNDL. MarketBeat recorded 2 mentions for Aurora Cannabis and 1 mentions for SNDL. SNDL's average media sentiment score of 0.00 beat Aurora Cannabis' score of -0.72 indicating that SNDL is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Negative SNDL 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer ACB or TLRY?

Tilray Brands has a consensus price target of $7.00, suggesting a potential upside of 93.91%. Given Tilray Brands' higher probable upside, analysts plainly believe Tilray Brands is more favorable than Aurora Cannabis. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50 Tilray Brands 2 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.29

Does the media refer more to ACB or TLRY?

In the previous week, Tilray Brands had 17 more articles in the media than Aurora Cannabis. MarketBeat recorded 19 mentions for Tilray Brands and 2 mentions for Aurora Cannabis. Tilray Brands' average media sentiment score of 0.24 beat Aurora Cannabis' score of -0.72 indicating that Tilray Brands is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Negative Tilray Brands 3 Very Positive mention(s) 4 Positive mention(s) 8 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral

Aurora Cannabis (ACB) Competitors

$4.46 +0.54 (+13.78%)

Closing price 04:00 PM Eastern

Extended Trading

$4.57 +0.11 (+2.49%)

As of 05:48 PM Eastern

Compare

ACB vs. CGC, CRON, OGI, SNDL, and TLRY

Should you buy Aurora Cannabis stock or one of its competitors? Aurora Cannabis's main competitors and comparable companies include Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), and Tilray Brands (TLRY). Companies are selected based on similarities in market, industry, and size.

How does Aurora Cannabis compare to Canopy Growth?

Canopy Growth (NASDAQ:CGC) and Aurora Cannabis (NASDAQ:ACB) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, risk, earnings and valuation.

Aurora Cannabis has a net margin of -32.26% compared to Canopy Growth's net margin of -65.33%. Aurora Cannabis' return on equity of 4.37% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	-65.33%	-21.91%	-14.34%
Aurora Cannabis	-32.26%	4.37%	3.45%

3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are held by institutional investors. 0.4% of Canopy Growth shares are held by insiders. Comparatively, 0.0% of Aurora Cannabis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Aurora Cannabis has lower revenue, but higher earnings than Canopy Growth. Aurora Cannabis is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	$251.01M	1.57	-$190.29M	-$0.45	N/A
Aurora Cannabis	$247.82M	1.04	-$88.13M	-$1.41	N/A

Canopy Growth has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.63, meaning that its stock price is 37% less volatile than the broader market.

In the previous week, Canopy Growth had 12 more articles in the media than Aurora Cannabis. MarketBeat recorded 14 mentions for Canopy Growth and 2 mentions for Aurora Cannabis. Canopy Growth's average media sentiment score of 0.90 beat Aurora Cannabis' score of -0.72 indicating that Canopy Growth is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Canopy Growth	9 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Aurora Cannabis	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Negative

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Summary

Canopy Growth beats Aurora Cannabis on 9 of the 16 factors compared between the two stocks.

How does Aurora Cannabis compare to Cronos Group?

Aurora Cannabis (NASDAQ:ACB) and Cronos Group (NASDAQ:CRON) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

Cronos Group has a consensus target price of $2.30, suggesting a potential downside of 28.57%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts plainly believe Cronos Group is more favorable than Aurora Cannabis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Cronos Group	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60

Cronos Group has a net margin of 39.08% compared to Aurora Cannabis' net margin of -32.26%. Cronos Group's return on equity of 4.85% beat Aurora Cannabis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-32.26%	4.37%	3.45%
Cronos Group	39.08%	4.85%	4.62%

Cronos Group has lower revenue, but higher earnings than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	$247.82M	1.04	-$88.13M	-$1.41	N/A
Cronos Group	$146.59M	8.10	-$9.45M	$0.20	16.10

47.6% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 8.7% of Cronos Group shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by insiders. Comparatively, 7.8% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Cronos Group had 1 more articles in the media than Aurora Cannabis. MarketBeat recorded 3 mentions for Cronos Group and 2 mentions for Aurora Cannabis. Cronos Group's average media sentiment score of 0.64 beat Aurora Cannabis' score of -0.72 indicating that Cronos Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aurora Cannabis	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Negative
Cronos Group	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Aurora Cannabis has a beta of 0.63, suggesting that its share price is 37% less volatile than the broader market. Comparatively, Cronos Group has a beta of 0.9, suggesting that its share price is 10% less volatile than the broader market.

Summary

Cronos Group beats Aurora Cannabis on 14 of the 17 factors compared between the two stocks.

How does Aurora Cannabis compare to Organigram Global?

Aurora Cannabis (NASDAQ:ACB) and Organigram Global (NASDAQ:OGI) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, risk, valuation, institutional ownership, media sentiment, profitability and dividends.

Organigram Global has a net margin of 28.14% compared to Aurora Cannabis' net margin of -32.26%. Aurora Cannabis' return on equity of 4.37% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-32.26%	4.37%	3.45%
Organigram Global	28.14%	-13.39%	-8.67%

Organigram Global has lower revenue, but higher earnings than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	$247.82M	1.04	-$88.13M	-$1.41	N/A
Organigram Global	$185.07M	0.73	-$17.70M	$0.46	2.07

In the previous week, Organigram Global had 1 more articles in the media than Aurora Cannabis. MarketBeat recorded 3 mentions for Organigram Global and 2 mentions for Aurora Cannabis. Organigram Global's average media sentiment score of 1.16 beat Aurora Cannabis' score of -0.72 indicating that Organigram Global is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aurora Cannabis	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Negative
Organigram Global	1 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Organigram Global	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

47.6% of Aurora Cannabis shares are held by institutional investors. Comparatively, 34.6% of Organigram Global shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by company insiders. Comparatively, 0.1% of Organigram Global shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Aurora Cannabis has a beta of 0.63, meaning that its share price is 37% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.5, meaning that its share price is 50% more volatile than the broader market.

Summary

Organigram Global beats Aurora Cannabis on 10 of the 16 factors compared between the two stocks.

How does Aurora Cannabis compare to SNDL?

Aurora Cannabis (NASDAQ:ACB) and SNDL (NASDAQ:SNDL) are related small-cap companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, media sentiment, valuation, profitability and risk.

SNDL has higher revenue and earnings than Aurora Cannabis. SNDL is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	$247.82M	1.04	-$88.13M	-$1.41	N/A
SNDL	$677.32M	0.47	-$11.29M	-$0.06	N/A

SNDL has a net margin of -2.36% compared to Aurora Cannabis' net margin of -32.26%. Aurora Cannabis' return on equity of 4.37% beat SNDL's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-32.26%	4.37%	3.45%
SNDL	-2.36%	-2.01%	-1.67%

Aurora Cannabis has a beta of 0.63, meaning that its share price is 37% less volatile than the broader market. Comparatively, SNDL has a beta of 0.93, meaning that its share price is 7% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
SNDL	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

47.6% of Aurora Cannabis shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Aurora Cannabis had 1 more articles in the media than SNDL. MarketBeat recorded 2 mentions for Aurora Cannabis and 1 mentions for SNDL. SNDL's average media sentiment score of 0.00 beat Aurora Cannabis' score of -0.72 indicating that SNDL is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aurora Cannabis	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Negative
SNDL	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Aurora Cannabis beats SNDL on 10 of the 16 factors compared between the two stocks.

How does Aurora Cannabis compare to Tilray Brands?

Aurora Cannabis (NASDAQ:ACB) and Tilray Brands (NASDAQ:TLRY) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk, media sentiment and institutional ownership.

In the previous week, Tilray Brands had 17 more articles in the media than Aurora Cannabis. MarketBeat recorded 19 mentions for Tilray Brands and 2 mentions for Aurora Cannabis. Tilray Brands' average media sentiment score of 0.24 beat Aurora Cannabis' score of -0.72 indicating that Tilray Brands is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aurora Cannabis	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Negative
Tilray Brands	3 Very Positive mention(s)	4 Positive mention(s)	8 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral

Tilray Brands has a consensus price target of $7.00, suggesting a potential upside of 93.91%. Given Tilray Brands' higher probable upside, analysts plainly believe Tilray Brands is more favorable than Aurora Cannabis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Tilray Brands	2 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.29

47.6% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 9.4% of Tilray Brands shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by company insiders. Comparatively, 1.6% of Tilray Brands shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Aurora Cannabis has higher earnings, but lower revenue than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	$247.82M	1.04	-$88.13M	-$1.41	N/A
Tilray Brands	$915.45M	0.54	-$121.40M	-$1.08	N/A

Aurora Cannabis has a beta of 0.63, meaning that its share price is 37% less volatile than the broader market. Comparatively, Tilray Brands has a beta of 1.91, meaning that its share price is 91% more volatile than the broader market.

Tilray Brands has a net margin of -13.11% compared to Aurora Cannabis' net margin of -32.26%. Aurora Cannabis' return on equity of 4.37% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-32.26%	4.37%	3.45%
Tilray Brands	-13.11%	-7.76%	-5.59%

Summary

Tilray Brands beats Aurora Cannabis on 9 of the 16 factors compared between the two stocks.

Get Aurora Cannabis News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ACB vs. The Competition

Export

Metric	Aurora Cannabis	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$293.11M	$12.12B	$7.17B	$13.38B
Dividend Yield	N/A	2.65%	2.53%	17.32%
P/E Ratio	-3.16	799.72	274.64	26.20
Price / Sales	1.18	755.20	608.14	90.60
Price / Cash	5.58	15.08	27.22	34.70
Price / Book	0.71	10.68	11.26	6.40
Net Income	-$88.13M	$2.83B	$3.49B	$381.07M
7 Day Performance	9.05%	-2.21%	-1.68%	-0.65%
1 Month Performance	12.91%	-6.56%	-5.97%	-4.50%
1 Year Performance	-21.06%	-4.54%	8.10%	1.82%

Aurora Cannabis Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ACB Aurora Cannabis	0.9798 of 5 stars	$4.46 +13.8%	N/A	-30.6%	$293.11M	$247.82M	N/A	1,028	News Coverage Analyst Upgrade Options Volume Gap Up High Trading Volume
CGC Canopy Growth	0.9441 of 5 stars	$0.93 -0.7%	N/A	-36.1%	$417.40M	$293.63M	N/A	1,128	Analyst Upgrade
CRON Cronos Group	1.287 of 5 stars	$3.32 -2.4%	$2.30 -30.7%	+24.8%	$1.22B	$179.09M	16.60	610	Positive News
OGI Organigram Global	2.7524 of 5 stars	$1.10 +0.9%	N/A	-49.3%	$155.14M	$309.18M	2.39	1,139	Positive News
SNDL SNDL	0.8289 of 5 stars	$1.40 flat	N/A	-51.9%	$360.36M	$928.39M	N/A	2,751

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ACB) was last updated on 10/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aurora Cannabis (ACB) Competitors

ACB vs. CGC, CRON, OGI, SNDL, and TLRY

How does Aurora Cannabis compare to Canopy Growth?

Summary

How does Aurora Cannabis compare to Cronos Group?

Summary

How does Aurora Cannabis compare to Organigram Global?

Summary

How does Aurora Cannabis compare to SNDL?

Summary

How does Aurora Cannabis compare to Tilray Brands?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACB vs. The Competition

Aurora Cannabis Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aurora Cannabis (ACB) Competitors

ACB vs. CGC, CRON, OGI, SNDL, and TLRY

How does Aurora Cannabis compare to Canopy Growth?

Is CGC or ACB more profitable?

Do institutionals and insiders believe in CGC or ACB?

Which has better valuation and earnings, CGC or ACB?

Which has more risk & volatility, CGC or ACB?

Does the media prefer CGC or ACB?

Do analysts rate CGC or ACB?

Summary

How does Aurora Cannabis compare to Cronos Group?

Do analysts rate ACB or CRON?

Is ACB or CRON more profitable?

Which has better valuation & earnings, ACB or CRON?

Do insiders & institutionals hold more shares of ACB or CRON?

Does the media refer more to ACB or CRON?

Which has more volatility and risk, ACB or CRON?

Summary

How does Aurora Cannabis compare to Organigram Global?

Is ACB or OGI more profitable?

Which has preferable valuation and earnings, ACB or OGI?

Does the media favor ACB or OGI?

Do analysts prefer ACB or OGI?

Do insiders and institutionals believe in ACB or OGI?

Which has more risk & volatility, ACB or OGI?

Summary

How does Aurora Cannabis compare to SNDL?

Which has higher valuation & earnings, ACB or SNDL?

Is ACB or SNDL more profitable?

Which has more risk and volatility, ACB or SNDL?

Do analysts prefer ACB or SNDL?

Do institutionals and insiders believe in ACB or SNDL?

Does the media favor ACB or SNDL?

Summary

How does Aurora Cannabis compare to Tilray Brands?

Does the media refer more to ACB or TLRY?

Do analysts prefer ACB or TLRY?

Do insiders & institutionals have more ownership in ACB or TLRY?

Which has preferable valuation & earnings, ACB or TLRY?

Which has more risk & volatility, ACB or TLRY?

Is ACB or TLRY more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACB vs. The Competition

Aurora Cannabis Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools